Navigation Links
Transdermal Drug Delivery - Technologies, Markets, and Companies
Date:6/6/2011

NEW YORK, June 6, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Transdermal Drug Delivery - Technologies, Markets, and Companies

http://www.reportlinker.com/p0350370/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory

Benefits of this report

* Up-to-date one-stop information on transdermal drug delivery

* Description of 117 companies involved and 101 collaborations in this area

* Market analysis 2009-2019/

* Market values in major regions

* Strategies for developing markets for transdermal drug delivery

* A selected bibliography of 170 publications

* Text is supplemented by 17 tables and 10 figures

Who should read this report?

* Biotechnology companies developing transdermal technologies

* Drug delivery companies

* Pharmaceutical companies interested in transdermal drug delivery

* Pharmaceutical research institutes

Summary

This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers. The most commonly used transdermal system is the skin patch using various types of technologies. Nanoparticles as well as the use of physical agents to facilitate transcutaneous drug delivery is described. Microneedle and needleless technologies are also described. Transdermal technologies may be applied for several categories of pharmaceuticals used for the treatment of disorders of the skin or for systemic effect to treat diseases of other organs. Several transdermal products and applications include hormone replacement therapy, contraception, management of pain, angina pectoris, smoking cessation and neurological disorders such as Parkinson's disease. The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2009 to 2019. This market is analyzed according to geographical regions as well.

To order this report:

: Transdermal Drug Delivery - Technologies, Markets, and Companies

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
2. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
3. Actavis Encourages Consumers to Return Fentanyl Transdermal System 25 mcg/h
4. Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System 25 mcg/h
5. FDA Accepts Aricept® Patch (Donepezil Transdermal System) NDA for Review
6. Purdue Pharma L.P. to Present Data From Clinical Program for Butrans™ (buprenorphine) Transdermal System CIII at PAINWeek® 2010
7. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
8. New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen
9. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
10. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
11. Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Feb. 9, 2016  Jazz Pharmaceuticals plc (Nasdaq: ... 2015 fourth quarter and full year financial results on ... financial markets.  Company management will host a live audio ... p.m. GMT to discuss fourth quarter and full year ... update and guidance for 2016 financial results. ...
(Date:2/9/2016)... -- Amarantus BioScience Holdings, Inc. (OTCQB: ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference which ... New York City . The Company,s presentation will ... pm by Gerald E. Commissiong , President & ...
(Date:2/9/2016)... "Global Blood Monitoring & Cardiac Monitoring Devices Market Assessment & Forecast: ... global market for blood monitoring & cardiac monitoring devices was valued ... US$ 24,830.1 million by 2019 at a CAGR of 6.8% from ... Europe , Asia-Pacific , ... Africa . The three major factors determining growth of ...
Breaking Medicine Technology:
(Date:2/10/2016)... Melbourne, FLA (PRWEB) , ... February 09, 2016 ... ... the team at Clevens Face and Body Specialists are delighted to welcome a ... Certified ARNP joins Clevens Face and Body Specialists as a nurse practitioner performing ...
(Date:2/9/2016)... ... February 09, 2016 , ... Center ... who are diagnosed with autism spectrum disorder (ASD). Beginning Jan. 1, 2016, Medicaid ... applied behavior analysis (ABA) is key to providing effective treatment for individuals with ...
(Date:2/9/2016)... ... February 09, 2016 , ... Cirracore Enterprise Cloud, today announced ... to the cloud. Cirracore provides a secure VMware® vCloud Air based cloud ... Transformation Solutions (TSL Partners) provides a full range of services from planning, ...
(Date:2/9/2016)... ... February 10, 2016 , ... The Journal of Pain Research ... playing field .” , As corresponding author Dr John F. Peppin says “Terminology matters, ... diagnose our chronic pain patients. ‘Chronic cancer pain’ and ‘chronic non-cancer pain’ are ...
(Date:2/9/2016)... ... February 09, 2016 , ... IsoComforter, Inc., ... introduction of the newly designed, innovative shoulder wrap. The newly designed shoulder ... for the injured arm and shoulder to promote faster healing. It is highly ...
Breaking Medicine News(10 mins):